A global perspective on using implementation research to address hypertension-associated target organ damage

Emmanuel Peprah, Maria Lopez-Class, Susan Shero, Joylene John-Sowah, Michael Engelgau

Research output: Contribution to journalReview article

Abstract

Hypertension, a major risk factor for cardiovascular disease, imposes a significant public health burden and challenge to address it worldwide. Scaling up delivery of proven, effective interventions for hypertension could significantly advance the goal of reducing the global burden. Although significant progress has been made in many countries, some lament that large-scale initiatives focused on reducing blood pressure in global populations have not effectively addressed this challenge. Late-stage implementation research plays a critical role in determining effective and sustainable scale-up of these initiatives. In this article, we briefly discuss some of the global initiatives that have been funded by the National Heart, Lung, and Blood Institute of the US National Institutes of Health. Intervention delivery strategies in low resource settings must have demonstrated effectiveness and consideration for the social, cultural and physical context (eg, access, affordability, and availability of medications) in which a program is being delivered in order to be sustainable nationally and globally. Hence, the use of implementation research is central to determining sustainable delivery of evidence-based and tailored interventions focused on hypertension control. The sustained control of hypertension in global populations holds tremendous potential for reducing morbidity, premature mortality, and the adverse economic impact of cardiovascular disease in all regions.

Original languageEnglish (US)
Pages (from-to)395-398
Number of pages4
JournalEthnicity and Disease
Volume26
Issue number3
DOIs
StatePublished - Jun 1 2016

Fingerprint

Hypertension
Research
Cardiovascular Diseases
National Heart, Lung, and Blood Institute (U.S.)
Premature Mortality
National Institutes of Health (U.S.)
Population
Public Health
Economics
Blood Pressure
Morbidity

Keywords

  • Global Health
  • Hypertension
  • Implementation Research
  • Target Organ Damage

ASJC Scopus subject areas

  • Epidemiology

Cite this

A global perspective on using implementation research to address hypertension-associated target organ damage. / Peprah, Emmanuel; Lopez-Class, Maria; Shero, Susan; John-Sowah, Joylene; Engelgau, Michael.

In: Ethnicity and Disease, Vol. 26, No. 3, 01.06.2016, p. 395-398.

Research output: Contribution to journalReview article

Peprah, Emmanuel ; Lopez-Class, Maria ; Shero, Susan ; John-Sowah, Joylene ; Engelgau, Michael. / A global perspective on using implementation research to address hypertension-associated target organ damage. In: Ethnicity and Disease. 2016 ; Vol. 26, No. 3. pp. 395-398.
@article{7d29819389f947528e39e4b3fa8b143c,
title = "A global perspective on using implementation research to address hypertension-associated target organ damage",
abstract = "Hypertension, a major risk factor for cardiovascular disease, imposes a significant public health burden and challenge to address it worldwide. Scaling up delivery of proven, effective interventions for hypertension could significantly advance the goal of reducing the global burden. Although significant progress has been made in many countries, some lament that large-scale initiatives focused on reducing blood pressure in global populations have not effectively addressed this challenge. Late-stage implementation research plays a critical role in determining effective and sustainable scale-up of these initiatives. In this article, we briefly discuss some of the global initiatives that have been funded by the National Heart, Lung, and Blood Institute of the US National Institutes of Health. Intervention delivery strategies in low resource settings must have demonstrated effectiveness and consideration for the social, cultural and physical context (eg, access, affordability, and availability of medications) in which a program is being delivered in order to be sustainable nationally and globally. Hence, the use of implementation research is central to determining sustainable delivery of evidence-based and tailored interventions focused on hypertension control. The sustained control of hypertension in global populations holds tremendous potential for reducing morbidity, premature mortality, and the adverse economic impact of cardiovascular disease in all regions.",
keywords = "Global Health, Hypertension, Implementation Research, Target Organ Damage",
author = "Emmanuel Peprah and Maria Lopez-Class and Susan Shero and Joylene John-Sowah and Michael Engelgau",
year = "2016",
month = "6",
day = "1",
doi = "10.18865/ed.26.3.395",
language = "English (US)",
volume = "26",
pages = "395--398",
journal = "Ethnicity and Disease",
issn = "1049-510X",
publisher = "ISHIB",
number = "3",

}

TY - JOUR

T1 - A global perspective on using implementation research to address hypertension-associated target organ damage

AU - Peprah, Emmanuel

AU - Lopez-Class, Maria

AU - Shero, Susan

AU - John-Sowah, Joylene

AU - Engelgau, Michael

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Hypertension, a major risk factor for cardiovascular disease, imposes a significant public health burden and challenge to address it worldwide. Scaling up delivery of proven, effective interventions for hypertension could significantly advance the goal of reducing the global burden. Although significant progress has been made in many countries, some lament that large-scale initiatives focused on reducing blood pressure in global populations have not effectively addressed this challenge. Late-stage implementation research plays a critical role in determining effective and sustainable scale-up of these initiatives. In this article, we briefly discuss some of the global initiatives that have been funded by the National Heart, Lung, and Blood Institute of the US National Institutes of Health. Intervention delivery strategies in low resource settings must have demonstrated effectiveness and consideration for the social, cultural and physical context (eg, access, affordability, and availability of medications) in which a program is being delivered in order to be sustainable nationally and globally. Hence, the use of implementation research is central to determining sustainable delivery of evidence-based and tailored interventions focused on hypertension control. The sustained control of hypertension in global populations holds tremendous potential for reducing morbidity, premature mortality, and the adverse economic impact of cardiovascular disease in all regions.

AB - Hypertension, a major risk factor for cardiovascular disease, imposes a significant public health burden and challenge to address it worldwide. Scaling up delivery of proven, effective interventions for hypertension could significantly advance the goal of reducing the global burden. Although significant progress has been made in many countries, some lament that large-scale initiatives focused on reducing blood pressure in global populations have not effectively addressed this challenge. Late-stage implementation research plays a critical role in determining effective and sustainable scale-up of these initiatives. In this article, we briefly discuss some of the global initiatives that have been funded by the National Heart, Lung, and Blood Institute of the US National Institutes of Health. Intervention delivery strategies in low resource settings must have demonstrated effectiveness and consideration for the social, cultural and physical context (eg, access, affordability, and availability of medications) in which a program is being delivered in order to be sustainable nationally and globally. Hence, the use of implementation research is central to determining sustainable delivery of evidence-based and tailored interventions focused on hypertension control. The sustained control of hypertension in global populations holds tremendous potential for reducing morbidity, premature mortality, and the adverse economic impact of cardiovascular disease in all regions.

KW - Global Health

KW - Hypertension

KW - Implementation Research

KW - Target Organ Damage

UR - http://www.scopus.com/inward/record.url?scp=84979670112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979670112&partnerID=8YFLogxK

U2 - 10.18865/ed.26.3.395

DO - 10.18865/ed.26.3.395

M3 - Review article

VL - 26

SP - 395

EP - 398

JO - Ethnicity and Disease

JF - Ethnicity and Disease

SN - 1049-510X

IS - 3

ER -